Prognosis of Adult Asthma After Normalization of Bronchial Hyperresponsiveness by Inhaled Corticosteroid Therapy

References

• Gerritsen J, Koeter G H, Postma D S, et al. Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis 1989; 140: 1325–1330
   PubMed Web of Science ®Google Scholar
• Panhuysen C IM, Vonk J M, Koeter G H, et al. Adult patients may outgrow their asthma. A 25-year follow-up study. Am J Respir Crit Care Med 1997; 155: 1267–1272
   PubMed Web of Science ®Google Scholar
• Roorda R J, Gerritsen J, Aalderen van W MC, et al. Risk factors for the persistence of respiratory symptoms in childhood asthma. Am Rev Respir Dis 1993; 148: 1490–1495
   PubMed Web of Science ®Google Scholar
• Gooijer de A, Brand P LP, Gerritsen J, et al. Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children. Eur Respir J 1993; 6: 848–854
   Google Scholar
• Vonk J M, Postma D S, Boezen H M, et al. Childhood factors associated with asthma remission after 30 year follow up. Thorax 2004; 59: 925–929
   PubMed Web of Science ®Google Scholar
• Bronnimann S, Burrows B. A prospective study of the natural history of asthma. Remission and relapse rate. Chest 1986; 90: 480–484
   Google Scholar
• Radfold P J, Hopp R J, Biven R E, et al. Longitudinal changes in bronchial hyperresponsiveness in asthmatic and previously asthmatic children. Chest 1992; 101: 624–629
   Google Scholar
• Sears M R, Greene J M, Willan A R, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414–1422
   PubMed Web of Science ®Google Scholar
• Taylor D R, Cowan J O, Greene J M, et al. Asthma in remission. Can relapse in early adulthood be predicted at 19 years of age? Chest 2005; 127: 845–850
   Google Scholar
• Vonk J M, Jongepier H, Panhuysen C IM, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322–327
   PubMed Web of Science ®Google Scholar
• Cibella F, Cuttitta G, Bellia V, et al. Lung function decline in bronchial asthma. Chest 2002; 122: 1944–1948
   PubMed Web of Science ®Google Scholar
• Ulrik C S, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47: 14–18
   PubMed Web of Science ®Google Scholar
• Barnes P J, Pedersen S, Busse W W. Efficacy and safety of inhaled corticosteroids: New developments. Am J Respir Crit Care Med 1998; 157: S1
   Google Scholar
• Juniper E F, Frith P A, Hargreave F E. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981; 36: 575–579
   PubMed Web of Science ®Google Scholar
• Murray A B, Ferguson A C, Morrison B. Airway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1981; 68: 119–124
   PubMed Web of Science ®Google Scholar
• Waalkens H J, Essen-Zandvliet E E, Hughes M D, et al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. Am J Respir Crit Care Med 1993; 148: 1252–1257
   Google Scholar
• National Institute of Health, National Heart Lung and Blood Institute. National Asthma Education and Prevention Program: expert panel report; guidelines for the diagnosis and management of asthma, update on selected topics—2002. J Allergy Clin Immunol 2002; 110(5 suppl)S141–219
   Google Scholar
• Ryan G, Latimer K M, Juniper E F, et al. Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma. J Allergy Clin Immunol 1985; 75: 23–30
   Google Scholar
• Woolcock A J, Yan K, Salome C M. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy 1988; 18: 165–176
   PubMedGoogle Scholar
• Juniper E F, Kline P A, Vanzieleghem M A, et al. Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991; 87: 483–489
   PubMed Web of Science ®Google Scholar
• in't Veen J CCM, Smits H H, Hiemstra P S, et al. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999; 160: 93–99
   PubMedGoogle Scholar
• Leuppi J D, Salome C M, Jenkins C R, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163: 406–412
   PubMed Web of Science ®Google Scholar
• Foresi A, Mastropasqua B, Chetta A, et al. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma. Chest 2005; 127: 117–124
   PubMed Web of Science ®Google Scholar
• Smith A D, Cowan J O, Brassett K P, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163–2173
   PubMed Web of Science ®Google Scholar
• Bacharier L B. Step-down therapy for asthma: why, when, and how?. J Allergy Clin Immunol 2002; 109: 916–919
   PubMed Web of Science ®Google Scholar
• Bateman E D, Jacques L, Goldfrad C, et al. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. J Allergy Clin Immunol 2006; 117: 563–570
   PubMed Web of Science ®Google Scholar
• Peters S P, Anthonisen N, Castro M, et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Eng J Med 2007; 356: 2027–2039
   PubMed Web of Science ®Google Scholar
• NIH. Global Strategy for Asthma Management and Prevention. National Institutes of Health National Heart, Lung and Blood Institute. 2002
   Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
   PubMed Web of Science ®Google Scholar
• Hansel F K. On the Hansel stain. Ann Allergy 1977; 39: 142
   PubMedGoogle Scholar
• Chai H, Farr R S, Froehlich L A, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323–327
   PubMed Web of Science ®Google Scholar
• Solley G O, Gleich G J, Jordon R E, Schroeter A L. The late phase of the immediate wheal and flare skin reaction. J Clin Invest 1976; 58: 408–420
   PubMed Web of Science ®Google Scholar
• Hargreave F E, Dolovich J, Boulet L P. Inhalation provocation tests. Semin Respir Med 1983; 4: 224–236
   Google Scholar
• Porsbjerg C, von Linstow M L, Ulrik C S, et al. Risk factors for onset of asthma: a 12-year prospective follow-up study. Chest 2006; 129: 309–316
   PubMed Web of Science ®Google Scholar
• Bahceciler N N, Barlan B, Nuhoglu Y, et al. Which factors predict success after discontinuation of inhaled budesonide therapy in children with asthma?. J Asthma 2002; 39: 37–46
   PubMed Web of Science ®Google Scholar
• Vonk J M, Boezen H M. Predicting adult asthma in childhood. Curr Opin Pulm Med 2006; 12: 42–47
   Google Scholar
• Pepe C, Foley S, Shannon J, et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005; 116: 544–549
   PubMed Web of Science ®Google Scholar
• Chetta A, Foresi A, Del Donno M, et al. Airway remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997; 111: 852–857
   PubMed Web of Science ®Google Scholar
• Jeffery P K. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164(suppl)S28–38
   Google Scholar
• Bergeron C, Hauber H P, Gotfried M, et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma; Effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 2005; 116: 983–989
   PubMed Web of Science ®Google Scholar
• Olivieri D, Chetta A, Donno M D, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997; 155: 1864–1871
   PubMed Web of Science ®Google Scholar
• Toorn L M, Overbeek S E, Jongste J C, et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164: 2107–2113
   Google Scholar